Procurement News

News TI Ref No :

456663697

News Date :

19 Sep 2020

News Description :

United States ImmunoGen Presents Final Data From Phase 1b FORWARD II Triplet Cohort Evaluating Mirvetuximab Soravtansine in Combination With Carboplatin and Avastin at ESMO, United states

News Deadline :

19 Sep 2020

News Project Location :

United states

News Sector :

Healthcare & Medical - Health services Tenders , Healthcare and Medical Tenders

News Document Type :

Procurement News

News Organization Name :

Click for more details

News Original Document :

Click for more details

News Funding Agency :

Click for more details

Create account

Start your Business.

Name*

Email ID*

Mobile No*

Organization name*

Country*

Already have account? Login

Start with receiving Free Data Samples related to your Products and Services

Live Tender Updates from worldwide
Access to original Tender Documents
Information on Upcoming Projects and Contract Awards
Bid Assistance Services
Competitior Analysis & Industry Trends

Procurement News

Create account

Start your Business.

Congratulations!

Start with receiving Free Data Samples related to your Products and Services

Member Login